Halo Neuroscience is a neurotech company focused on using electrical neurostimulation to unlock human performance and treat human disease
Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training.The company was incorporated in 2013 and is based in San Francisco, CA.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 30, 2018 | Series B | $13M | 1 | TPG | — | Detail |